Phase 2a randomized controlled study investigating the safety and efficacy of PDA-002 in diabetic peripheral neuropathy.
Gibbons, Christopher H, Junhong Zhu, Xiaokui Zhang, Nassir Habboubi, Robert Hariri, and Aristidis Veves. 2021. “Phase 2a Randomized Controlled Study Investigating the Safety and Efficacy of PDA-002 in Diabetic Peripheral Neuropathy.”. 2021.